Gelteq Limited (GELS)
NASDAQ: GELS · Real-Time Price · USD
1.290
+0.030 (2.38%)
At close: Aug 22, 2025, 4:00 PM
1.290
0.00 (0.00%)
Pre-market: Aug 25, 2025, 4:04 AM EDT

Gelteq Revenue

Gelteq had revenue of 155.71K AUD in the quarter ending December 31, 2024, with 305.06% growth. This brings the company's revenue in the last twelve months to 377.85K, up 10.19% year-over-year. In the fiscal year ending June 30, 2024, Gelteq had annual revenue of 143.31K, down -58.21%.

Revenue (ttm)
377.85K AUD
Revenue Growth
+10.19%
P/S Ratio
46.17
Revenue / Employee
47,231 AUD
Employees
8
Market Cap
12.45M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 2024143.31K-199.59K-58.21%
Jun 30, 2023342.90K-29.17K-7.84%
Jun 30, 2022372.07K212.20K132.73%
Jun 30, 2021159.87K--
Jun 30, 2020---
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings